300 related articles for article (PubMed ID: 31040664)
1. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
Li X; Xia S; Zhou W; Ji R; Zhan W
Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
[TBL] [Abstract][Full Text] [Related]
2. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging.
Jiang W; Fang H; Liu F; Zhou X; Zhao H; He X; Guo D
Int J Nanomedicine; 2019; 14():5611-5622. PubMed ID: 31413566
[No Abstract] [Full Text] [Related]
3. Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer.
Cheng YA; Wu TH; Wang YM; Cheng TL; Chen IJ; Lu YC; Chuang KH; Wang CK; Chen CY; Lin RA; Chen HJ; Liao TY; Liu ES; Chen FM
J Nanobiotechnology; 2020 Aug; 18(1):118. PubMed ID: 32854720
[TBL] [Abstract][Full Text] [Related]
4. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An
Xu YH; Yang J; Meng J; Wang H
Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234
[TBL] [Abstract][Full Text] [Related]
5. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
6. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.
Hu H; Dai A; Sun J; Li X; Gao F; Wu L; Fang Y; Yang H; An L; Wu H; Yang S
Nanoscale; 2013 Nov; 5(21):10447-54. PubMed ID: 24057072
[TBL] [Abstract][Full Text] [Related]
8. Imaging specificity of MR-optical imaging agents following the masking of surface charge by poly(ethylene glycol).
Wu SC; Lin KL; Wang TP; Tzou SC; Singh G; Chen MH; Cheng TL; Chen CY; Liu GC; Lee TW; Hu SH; Wang YM
Biomaterials; 2013 May; 34(16):4118-4127. PubMed ID: 23465830
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer.
Sui Y; Li Y; Li Y; Jin H; Zheng Y; Huang W; Chen S
J Photochem Photobiol B; 2020 Jan; 202():111669. PubMed ID: 31739258
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
11. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
12. [Preclinical application of MR and fluorescent dual-modality imaging combined with photothermal therapy in HER-2 positive breast cancer].
Luo XJ; Li J; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):587-593. PubMed ID: 30139028
[No Abstract] [Full Text] [Related]
13. T
Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
[TBL] [Abstract][Full Text] [Related]
14. Targeted gold nanoshelled hybrid nanocapsules encapsulating doxorubicin for bimodal imaging and near-infrared triggered synergistic therapy of Her2-positve breast cancer.
Dong Q; Wan C; Yang H; Zheng D; Xu L; Zhou Z; Xie S; Du J; Li F
J Biomater Appl; 2020 Sep; 35(3):430-445. PubMed ID: 32515640
[TBL] [Abstract][Full Text] [Related]
15. Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.
Alric C; Hervé-Aubert K; Aubrey N; Melouk S; Lajoie L; Même W; Même S; Courbebaisse Y; Ignatova AA; Feofanov AV; Chourpa I; Allard-Vannier E
J Nanobiotechnology; 2018 Feb; 16(1):18. PubMed ID: 29466990
[TBL] [Abstract][Full Text] [Related]
16. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
[TBL] [Abstract][Full Text] [Related]
17. Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.
Jie LY; Cai LL; Wang LJ; Ying XY; Yu RS; Zhang MM; Du YZ
Int J Nanomedicine; 2012; 7():3981-9. PubMed ID: 22866005
[TBL] [Abstract][Full Text] [Related]
18. Her2-Functionalized Gold-Nanoshelled Magnetic Hybrid Nanoparticles: a Theranostic Agent for Dual-Modal Imaging and Photothermal Therapy of Breast Cancer.
Dong Q; Yang H; Wan C; Zheng D; Zhou Z; Xie S; Xu L; Du J; Li F
Nanoscale Res Lett; 2019 Aug; 14(1):235. PubMed ID: 31448377
[TBL] [Abstract][Full Text] [Related]
19. The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents.
Chen A; Sun J; Liu S; Li L; Peng X; Ma L; Zhang R
Biomater Sci; 2020 Jan; 8(1):379-390. PubMed ID: 31728481
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.
Duan D; Wang A; Ni L; Zhang L; Yan X; Jiang Y; Mu H; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2018; 13():1831-1840. PubMed ID: 29606874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
